A case series of serious and unexpected adverse drug reactions under treatment with cariprazine.
Johannes HeckCatharina MeissnerDirk O StichtenothChristoph SchroederAdrian GrohGregor R SzycikDetlef DegnerIvana AdamovicMichael SchneiderCatherine GlockerEckart RütherStefan BleichRenate GrohmannSermin TotoPublished in: Clinical case reports (2021)
Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring ("black triangle" label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.